Obesity and Kidney Disease: Hidden Consequences of the Epidemic

  title={Obesity and Kidney Disease: Hidden Consequences of the Epidemic},
  author={Csaba Pal Kovesdy and Susan L. Furth and Carmine Zoccali},
  journal={Kidney Diseases},
  pages={33 - 41}
Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease, and also for chronic kidney disease. A high body mass index is one of the strongest risk factors for new-onset chronic kidney disease. In individuals affected by obesity, a compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The… 

Figures and Tables from this paper

Obesity in the critically ill: a narrative review

In hospitalized and ICU patients and in patients with chronic illnesses, a J-shaped relationship between BMI and mortality has been demonstrated, with overweight and moderate obesity being protective compared with a normal BMI or more severe obesity (the still debated and incompletely understood “obesity paradox”).

Obesity as a risk factor for COVID-19: an overview

Abstract The current coronavirus disease-2019 (COVID-19) pandemic presents a huge challenge for health-care systems worldwide. Many different risk factors are associated with disease severity, such

NGAL and SMAD1 gene expression in the early detection of diabetic nephropathy by liquid biopsy

The data suggest the potential use of NGAL and SMAD1 gene expression in peripheral blood and urine samples as early biomarkers of DN.

Impact of kidney hyperfiltration on concentrations of selected perfluoroalkyl acids among US adults for various disease groups

  • R. Jain
  • Medicine
    Environmental Science and Pollution Research
  • 2021
For almost every PFAA, for all seven disease groups except the albuminuria only group, hyperfiltrators had lower adjusted geometric means (AGM) than normal filtrators, and AGMs for the anemia only group were the lowest for everyPFAA as compared with other disease groups among hyper Filtrators.

Neuroendocrine microRNAs linked to energy homeostasis: future therapeutic potential.

Current evidence demonstrating the regulation of feeding-related neuropeptides by brain-derived microRNAs as well as theregulation of specific miRNAs by nutrients and other peripheral signals is summarized.



Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease.

The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals

  • M. Blüher
  • Medicine, Biology
    Current opinion in lipidology
  • 2010
Recommendations for obesity treatment should distinguish the metabolically ‘ healthy’ from ‘unhealthy’ obese phenotype to identify early the obese person who will benefit the most from losing weight.

Body Mass Index and Risk for End-Stage Renal Disease

The hypothesis that overweight and obesity are risk factors for developing end-stage renal disease among a large, community-based sample of men and women is examined.

Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.

Obesity adults with hypertension have an increased risk for chronic kidney disease, according to the results of the HDFP study.

Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension

An abnormal WC, but not BMI appears to be independently associated with MAU, an early marker of cardiovascular and renal risk, underlining the prognostic importance of abdominal fat accumulation beyond general obesity.

Association between body mass index and CKD in apparently healthy men.

  • R. GelberT. Kurth J. Gaziano
  • Medicine
    American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2005
In this large cohort of initially healthy men, BMI was associated significantly with increased risk for CKD after 14 years, and strategies to decrease CKD risk might include prevention of overweight and obesity.

Obesity and risk for chronic renal failure.

Obesity seems to be an important-and potentially preventable-risk factor for CRF, and the strongest association was with diabetic nephropathy, but two- to three-fold risk elevations were observed for all major subtypes of CRF.

Increasing body mass index and obesity in the incident ESRD population.

Temporal trends in mean body mass index (BMI) and obesity prevalence were examined among incident patients with ESRD by year of dialysis initiation between 1995 and 2002, and these trends were compared with those in the US population during this same period.

Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.

Participants with prehypertension are not at increased risk of serious kidney outcomes if BMI is less than 30.0 kg/m(2) or greater, however, the risk of kidney disease increases substantially if pre Hypertension is present in obese participants.